KTP-001

N/A

Report date: 2023/10/16 20:15:33

Base Information

Drug NameKTP-001
Drug Alias NameRecombinant human matrix metalloproteinase - Kaketsuken/TeijinKTP-001
ClassificationBiologics
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsIntervertebral Disc Displacement
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeijin Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeijin America Inc
Active IndicationsN/A
Inactive IndicationsIntervertebral Disc Displacement

Other Information

ATC CodeN/A
Related LinksN/A